Skip to main content

Drug Interactions between kanamycin and typhoid vaccine, live

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

kanamycin typhoid vaccine, live

Applies to: kanamycin and typhoid vaccine, live

If you are currently being treated with kanamycin or have been treated within the last 3 days, you should talk to your doctor before taking typhoid vaccine, live. Antibiotics like kanamycin can reduce the activity of the vaccine. To ensure adequate vaccine response, you should generally not take typhoid vaccine, live until at least 3 days after you complete your antibiotic therapy. If you have already started taking typhoid vaccine, live, it may be advisable to wait at least 3 days after the last dose of vaccine before using kanamycin, depending on the urgency of the antibiotic treatment. You should consult with your physician on what is the best course of action for you. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.